A new report from Deloitte projects Canadians will create C$4.34 billion in sales of legal recreational cannabis product during 2019.

Deloitte’s latest cannabis market projection report released on Tuesday (June 5) indicates the entire Canadian cannabis market has the potential to reach close to C$7.2 billion by 2019.


As part of this report, the research firm surveyed cannabis consumers on their consumption trends and how that may change with the upcoming legalization of recreational cannabis in the country.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

According to the Canadian Press the results from an online survey of 1,500 Canadians, which took place between March 6-20, created the projection of C$4.34 billion for adult-use cannabis.

“Executed well, legalization will also help shift a considerable proportion of cannabis consumption to legal channels in the years to come,” Deloitte said.

In its conclusion Deloitte wrote the effect of legalization for cannabis in Canada, on its own, won’t move consumers to switch from illegal sources into legal government approved retailers. “[O]ur research suggests the right mix of quality, price and safety could just do the trick.”

Canadian licensed producers are working not only to develop the product needed for their sales projections but to entice consumers into joining legal avenues for the consumption of the drug, Allan Rewak, executive director of the Cannabis Canada Council, told the Investing News Network (INN).

During the Lift & Co Cannabis Expo in Toronto in late May, Rewak said a mission for the council, a grouping representing the interests of LPs, is to “migrate” consumers into the government approved market.

The study also found “current and likely consumers” are, at present, expecting to pay “slightly more” for legal products. On the things needed to really entice consumers away from illegal suppliers, Deloitte wrote:

High product quality and integrity (as affirmed by quality testing) as well as a range of competitive price points will be needed to persuade current consumers to move their purchases over to legal sources. Delivering a superior customer experience will be of vital importance.

Investor takeaway

The promise of the sales from the legalized adult-use market in Canada is starting to become a reality. Projections are closing in on the first year of sales and this latest one by Deloitte shows a high expectation of the growth the industry will see during 2019.

Don’t forget to follow us @INN_Cannabis for real-time news updates! Stay tuned to our cannabis channel for more stories from Lift.

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less